Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | DGKA | P23743 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | RAD52 | P43351 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | PAM | P19021 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11041535 | 1.00 | FAAH (0.50) | FAAHNAAAHTTDGKATDP1 | |
| SCHEMBL11040479 | 1.00 | FAAH (0.50) | FAAHNAAAHTTDGKATDP1 | |
| SCHEMBL29267685 | 0.98 | FAAH (0.47) | FAAHNAAAHTTDGKATDP1 | |
| Butane SCHEMBL6079989 | 0.93 | FAAH (0.57) | FAAHNAAAHTTDGKARAD52 | |
| Butane SCHEMBL10792124 | 0.93 | FAAH (0.57) | FAAHNAAAHTTDGKARAD52 | |
| SCHEMBL29267684 | 0.91 | FAAH (0.44) | FAAHNAAADGKATSHRALDH1A1 | |
| Butane SCHEMBL23607922 | 0.90 | FAAH (0.54) | FAAHNAAAHTTDGKARAD52 | |
| SCHEMBL11041532 | 0.89 | FAAH (0.55) | FAAHNAAAHTTDGKARAD52 | |
| SCHEMBL11040477 | 0.89 | FAAH (0.55) | FAAHNAAAHTTDGKARAD52 | |
| SCHEMBL11037465 | 0.89 | FAAH (0.55) | FAAHNAAAHTTDGKARAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230227424-A1 | ULTRAVIOLET ABSORBING AGENT, RESIN COMPOSITION, CURED SUBSTANCE, OPTICAL MEMBER, METHOD OF PRODUCING ULTRAVIOLET ABSORBING AGENT, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2023-07-20 | — | — | US | disclosed |
| CN-116018373-A | Ultraviolet absorber, resin composition, cured product, optical member, method for producing ultraviolet absorber, and compound | 富士胶片株式会社 | 2023-04-25 | — | — | CN | disclosed |
| US-4476106-A | Process for the extemporaneous preparation of an injectable fatty acid tagged in the omega position by means of radioactive iodine | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1984-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230227424-A1 | ULTRAVIOLET ABSORBING AGENT, RESIN COMPOSITION, CURED SUBSTANCE, OPTICAL MEMBER, METHOD OF PRODUCING ULTRAVIOLET ABSORBING AGENT, AND COMPOUND | F12, C9, UNC93B1 | FAAH 181/4885NAAA 402/4885HTT 3750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.